Role of open chemical data in aiding drug discovery and design

Future Medicinal Chemistry

Volumn 2, Issue 6, 2010, Pages 903-907

  Gaulton, Anna ^a   Overington, John P ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; DATA BASE; DRUG ACTIVITY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; EDITORIAL; PHARMACODYNAMICS; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; STRUCTURE ACTIVITY RELATION;

DATABASES, FACTUAL; DRUG DESIGN; DRUG DISCOVERY;

EID: 77953642333     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.10.191     Document Type: Editorial

References (33)

1. Austin CP, Brady LS, Insel TR, Collins FS. NIH Molecular Libraries Initiative. Science 306(5699), 1138-1139 (2004).
2. Wang Y, Bolton E, Dracheva S et al. An overview of the PubChem BioAssay resource. Nucleic Acids Res. 38(Database issue), D255-266 (2010).
3. Seiler KP, George GA, Happ MP et al. ChemBank: a small-molecule screening and cheminformatics resource database. Nucleic Acids Res. 36(Database issue), D351-D359 (2008).
4. Liu T, Lin Y, Wen X, Jorrisen RN, Gilson MK. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 35(Database issue), D198-201 (2007).
5. Harmar AJ, Hills RA, Rosser EM et al. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res. 37(Database issue), D680-685 (2009).
6. Inglese J, Shamu C, Gu R. Reporting data from high-throughput screening of small-molecule libraries. Nat. Chem. Biol. 3(8), 438-441 (2007).
7. Judson RS, Houck KA, Kavlock RJ et al. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118(4), 485-492 (2010).
8. Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health protection. Science 319(5865), 906-907.
9. Villoutreix BO, Renault N, Lagorce D, Sperandio O, Montes M, Miteva MA. Free resources to assist structure-based virtual ligand screening experiments. Curr. Protein Pept. Sci. 8(4), 381-411 (2007).
10. Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45(1), 177-182 (2005).
11. Blum LC, Reymond JL. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. J. Am. Chem. Soc. 131(25), 8732-8733 (2009).
12. Wishart DS, Knox C, Guo AC et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36(Database issue), D901-D906 (2008).
13. Richard AM. DSSTox website launch: improving public access to databases for building structure-toxicity prediction models. Preclinica 2, 103-108 (2004).
14. Richard AM, Williams CR. Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. Mutat. Res. 499(1), 27-52 (2002).
15. Hochstein C, Arnesen S, Goshorn J. Environmental health and toxicology resources of the United States National Library of Medicine. Med. Ref. Serv. Q. 26(3), 21-45 (2007)
16. Barnes MR, Harland L, Foord SM et al. Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery. Nat. Rev. Drug Discov. 8(9), 701-708 (2009).
17. Hunter AJ. The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. Drug Discov. Today 13(9-10), 371-373 (2008).
18. Edwards AM, Bountra C, Kerr DJ, Willson TM. Open access chemical and clinical probes to support drug discovery. Nat. Chem. Biol. 5(7), 436-440 (2009).
19. Feng BY, Simeonov A, Jadhav A et al. A high-throughput screen for aggregation-based inhibition in a large compound library. J. Med. Chem. 50(10), 2385-2390 (2007).
20. Soares KM, Blackmon N, Shun TY et al. Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. Assay Drug Dev. Technol. (2010) in press.
21. Young D, Martin T, Venkatapathy R, Harten P. Are the chemical structures in your QSAR correct? QSAR Comb. Sci. 27(11-12), 1337-1345 (2008).
22. Kuhn T, Willighagen EL, Zielesny A, Steinbeck C. CDK-Taverna: an open workflow environment for cheminformatics. BMC Bioinformatics 11(1), 159 (2010).
23. Spjuth O, Helmus T, Willighagen EL et al. Bioclipse: an open source workbench for chemo-and bioinformatics. BMC Bioinformatics 8, 59 (2007).
24. Berthold MR, Cebron N, Dill F et al. KNIME: The Konstanz Information Miner. In: Data Analysis, Machine Learning and Applications. Preisach C, Schmidt-Thieme L (Eds). Springer-Verlag, Berlin, 319-326 (2008).
25. Jentzsch A, Hassanzadeh O, Bizer C, Andersson B, Stephens S. Enabling tailored therapeutics with linked data. Presented at: The 2nd Workshop about Linked Data on the Web. Madrid, Spain, 20 April 2009.
26. Belleau F, Nolin MA, Tourigny N, Rigault P, Morissette J. Bio2RDF: towards a mashup to build bioinformatics knowledge systems. J. Biomed. Inform. 41(5), 706-716 (2008).
27. Heller SR, McNaught AD. The IUPAC international chemical identifier (InChI). Chem. Int. 31(1), 7 (2009).
28. Agüero F, Al-Lazikani B, Aslett M et al. Genomic-scale prioritization of drug targets: the TDR targets database. Nat. Rev. Drug Discov. 7(11), 900-907 (2008).
29. Ekins S, Williams AJ. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development. Lab Chip 10(1), 13-22 (2010).
30. Filippov IV, Nicklaus MC. Optical structure recognition software to recover chemical information: OSRA, an open source solution. J. Chem. Inf. Model. 49(3), 740-743 (2009).
31. Munos B. Lessons for 60 years of pharmaceutical innovation. Nat. Rev. Drug Discov. 8(12), 959-968 (2009).
32. Melese T, Lin SM, Chang JL, Cohen NH. Open innovation networks between academia and industry: an imperative for breakthrough therapies. Nat. Med. 15(5), 502-507 (2009).
33. Munos BH, Chin WW. A call for sharing: adapting pharmaceutical research to new realities. Sci. Transl. Med. 1(9), 9 (2009).